Xenon Pharmaceuticals Inc. logo

XENEXenon Pharmaceuticals Inc.

XENE Stock Price, Valuation & Chart | Xenon Pharmaceuticals Inc.

Compare
$37.040-0.52 (-1.38%)

At close · 20 Nov 2026, 09:00 pm

XENE Historical price chart

XENE Key Stats

Fair value estimate
Disclaimer

General advice only. Model estimate, not a price target or a recommendation to buy, sell or hold. Not based on your objectives, financial situation or needs: consider the product disclosure statement and your own circumstances. Alphacentric Technology Pty Ltd t/a Tickerplace is a CAR (No. 001324046) of MF & Co. Asset Management Pty Ltd (AFSL 520442).

Market Capitalization3.64B
PE Ratio-7.88
EPS-4.7
Trading Volume1.08M
Today's High/Low37.91/36.8
Dividend Yield0.00
52 Week High/Low72.66/33.38
Shares Outstanding98.28M

Price and calculated levels

A preview of the XENE chart Pro members see. Dollar amounts stay locked. Each line is a calculated margin of safety or premium price, not a forecast.

Price $•••$•••+100%$•••+90%$•••+80%$•••+60%$•••+40%$•••+20%$•••Fair value$•••−20%$•••−30%$•••−40%$•••−50%$•••−60%
XENE Financial Statement
XENE Analyst ratings
XENE Analysis & performance metrics

XENE Company profile

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its…

XENE Management team

Management
Ian C. Mortimer C.M.A., CPA, M.B.A.CEO
President, Chief Executive Officer & Director
Sherry Aulin C.A., CPACFO
Chief Financial Officer
Shelley McClCoskey B.A.
Executive Vice President of Human Resources
Christopher John Kenney M.D.
Chief Medical Officer
James R. Empfield Ph.D.
Executive Vice President of Drug Discovery
Matthew D. Ronsheim Ph.D.COO
Chief Operating Officer
Robin P. Sherrington Ph.D.
Executive Vice President of Strategy & Innovation
Andrea DiFabio J.D.
Chief Legal Officer & Corporate Secretary
Total 8 executives

XENE Frequently asked questions

What is Xenon Pharmaceuticals Inc. (XENE) Stock Price?

Current stock price of Xenon Pharmaceuticals Inc. (XENE) stock is $37.040. The stock price is -1.38% lower in the session. The intraday range can be seen from this page. Volume of Xenon Pharmaceuticals Inc. (XENE) stock is 1.08M.

Last updated at 20 Nov 2026, 09:00 pm.

Why is the Xenon Pharmaceuticals Inc. (XENE) stock price going up or down today?

The stock price of Xenon Pharmaceuticals Inc. (XENE) can change with earnings, company news, and overall market sentiment. Xenon Pharmaceuticals Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Xenon Pharmaceuticals Inc. stock expensive at its current price?

Whether Xenon Pharmaceuticals Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XENE on this page is -7.88. EPS on this page is -4.70. Compare those figures with peers and growth expectations before deciding if the current Xenon Pharmaceuticals Inc. price is justified.

How has the stock price of Xenon Pharmaceuticals Inc. (XENE) performed historically?

Historical performance for Xenon Pharmaceuticals Inc. (XENE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XENE reacted to past earnings and market events.

Should I buy Xenon Pharmaceuticals Inc. (XENE) stock, at this price?

Buying Xenon Pharmaceuticals Inc. (XENE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.